Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The thrombospondin-related anonymous protein (TRAP) is an essential transmembrane molecule in Plasmodium sporozoites. TRAP displays adhesive motifs on the extracellular portion, whereas its cytoplasmic tail connects to actin via
aldolase
, thus driving parasite motility and host cell invasion. The minimal requirements for the TRAP binding to
aldolase
were scanned here and found to be shared by different human proteins, including the
Wiskott-Aldrich syndrome protein
(
WASp
) family members. In vitro and in vivo binding of
WASp
members to
aldolase
was characterized by biochemical, deletion mapping, mutagenesis, and co-immunoprecipitation studies. As in the case of TRAP, the binding of
WASp
to
aldolase
is competitively inhibited by the enzyme substrate/products. Furthermore, TRAP and
WASp
, but not other unrelated
aldolase
binders, compete for the binding to the enzyme in vitro. Together, our results define a conserved
aldolase
binding motif in the
WASp
family members and suggest that
aldolase
modulates the motility and actin dynamics of mammalian cells. These findings along with the presence of similar
aldolase
binding motifs in additional human proteins, some of which indeed interact with
aldolase
in pull-down assays, suggest supplementary, non-glycolytic roles for this enzyme.
...
PMID:Characterization of an aldolase-binding site in the Wiskott-Aldrich syndrome protein. 1627 21
Aldolase plays essential catalytic roles in glycolysis and gluconeogenesis. However,
aldolase
is a highly abundant protein that is remarkably promiscuous in its interactions with other cellular proteins. In particular,
aldolase
binds to highly acidic amino acid sequences, including the C terminus of the
Wiskott-Aldrich syndrome protein
, an actin nucleation-promoting factor. Here we report the crystal structure of tetrameric rabbit muscle
aldolase
in complex with a C-terminal peptide of
Wiskott-Aldrich syndrome protein
. Aldolase recognizes a short, four-residue DEWD motif (residues 498-501), which adopts a loose hairpin turn that folds around the central aromatic residue, enabling its tryptophan side chain to fit into a hydrophobic pocket in the active site of
aldolase
. The flanking acidic residues in this binding motif provide further interactions with conserved
aldolase
active site residues Arg-42 and Arg-303, aligning their side chains and forming the sides of the hydrophobic pocket. The binding of
Wiskott-Aldrich syndrome protein
to
aldolase
precludes intramolecular interactions of its C terminus with its active site and is competitive with substrate as well as with binding by actin and cortactin. Finally, based on this structure, a novel naphthol phosphate-based inhibitor of
aldolase
was identified, and its structure in complex with
aldolase
demonstrated mimicry of the
Wiskott-Aldrich syndrome protein
-
aldolase
interaction. The data support a model whereby
aldolase
exists in distinct forms that regulate glycolysis or actin dynamics.
...
PMID:A hydrophobic pocket in the active site of glycolytic aldolase mediates interactions with Wiskott-Aldrich syndrome protein. 1732 59